CATALOGO DEI PRODOTTI DELLA RICERCA

Granata, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.822
NA - Nord America 2.721
AS - Asia 1.827
SA - Sud America 267
AF - Africa 35
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 7.681
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.675
RU - Federazione Russa 1.071
SG - Singapore 673
GB - Regno Unito 569
CN - Cina 565
IT - Italia 319
SE - Svezia 210
BR - Brasile 204
VN - Vietnam 197
FR - Francia 177
HK - Hong Kong 142
IE - Irlanda 137
DE - Germania 124
FI - Finlandia 89
KR - Corea 61
ID - Indonesia 35
IN - India 31
AR - Argentina 28
UA - Ucraina 28
TR - Turchia 27
AT - Austria 19
BE - Belgio 18
CA - Canada 18
JP - Giappone 16
MX - Messico 16
IQ - Iraq 12
ZA - Sudafrica 12
EC - Ecuador 11
PL - Polonia 10
NL - Olanda 9
PK - Pakistan 8
BD - Bangladesh 7
ES - Italia 7
RO - Romania 7
CO - Colombia 6
MY - Malesia 6
VE - Venezuela 6
AU - Australia 5
CH - Svizzera 5
UZ - Uzbekistan 5
CL - Cile 4
IL - Israele 4
MA - Marocco 4
NG - Nigeria 4
PH - Filippine 4
PY - Paraguay 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
SA - Arabia Saudita 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
PT - Portogallo 1
SV - El Salvador 1
TH - Thailandia 1
Totale 7.679
Salva come PNG Salva come JPEG
Città #
Southend 487
Moscow 369
Singapore 369
Chandler 359
Ashburn 345
San Jose 252
Dallas 164
Jacksonville 155
Hong Kong 139
Dublin 133
Ann Arbor 108
Beijing 106
Woodbridge 96
Verona 91
New York 64
Wilmington 55
Lawrence 50
Princeton 50
The Dalles 50
Houston 45
Dong Ket 40
Jinan 36
Redmond 36
Council Bluffs 35
Ho Chi Minh City 35
Columbus 31
Hanoi 31
Los Angeles 31
Nanjing 28
Redondo Beach 28
Shenyang 27
São Paulo 24
Seattle 23
Helsinki 22
Hebei 20
Jakarta 20
Santa Clara 20
Tianjin 19
Orem 18
Brussels 17
Kent 17
Munich 17
Sindelfingen 17
Tokyo 16
Atlanta 15
Boardman 15
Ningbo 15
Lancaster 14
Rome 14
Vienna 14
Buffalo 13
Taizhou 13
Changsha 12
Denver 11
Padova 11
Zhengzhou 11
Brooklyn 10
Guangzhou 10
Jiaxing 10
Seoul 10
Ankara 9
Nanchang 9
Phoenix 9
Rio de Janeiro 9
Auburn Hills 8
Bologna 8
Haikou 8
Hangzhou 8
Milan 8
Nuremberg 8
Porto Alegre 8
Quito 8
Redwood City 8
San Francisco 8
Barnet 7
Biên Hòa 7
Boston 7
Chicago 7
London 7
Manchester 7
Taiyuan 7
Turku 7
Baghdad 6
Chennai 6
Johannesburg 6
Montreal 6
Venice 6
Warsaw 6
Washington 6
Amsterdam 5
Da Nang 5
Frankfurt am Main 5
Fuzhou 5
Haiphong 5
Lanzhou 5
Norwalk 5
Querétaro 5
Stockholm 5
Toronto 5
Turin 5
Totale 4.562
Salva come PNG Salva come JPEG
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 256
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 252
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 203
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 196
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 185
mTOR inhibitors and renal allograft: Yin and Yang. 184
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 182
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 180
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 180
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 178
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 177
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 177
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 176
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 175
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 170
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 168
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 167
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 166
Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. 165
DISTURBI PSICOLOGICI, QUALITÀ DI VITA E PRODUZIONE DI CITOCHINE NEI PAZIENTI IN EMODIALISI 165
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 164
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 161
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 159
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 158
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 157
Dialysis-related systemic microinflammation is associated with specific genomic patterns 157
Mitochondria: a new therapeutic target in chronic kidney disease. 155
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 154
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 152
mTOR Inhibition Role in Cellular Mechanisms 152
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 150
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 148
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 148
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 146
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 146
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 144
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 144
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 143
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 142
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 139
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 138
Analysis of urinary exosomes applications for rare kidney disorders. 134
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 128
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 126
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 111
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 105
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 103
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. 96
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 82
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 73
Totale 7.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.182
article - articoli 23.031
book - libri 0
conference - conferenze 2.151
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021134 0 0 0 0 0 0 0 0 0 6 40 88
2021/2022399 25 76 11 67 8 17 28 31 12 9 25 90
2022/20231.002 62 140 83 172 85 228 8 51 119 6 32 16
2023/2024450 23 39 49 40 57 81 9 40 3 10 82 17
2024/20251.054 52 67 47 202 49 37 68 52 152 50 98 180
2025/20263.056 225 136 173 561 861 247 308 167 177 201 0 0
Totale 7.817